e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication
Artículo científico (JournalArticle)
Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain
Background: Cutaneous squamous cell carcinoma (cSCC) is the leading cause of death in patients with recessive dystrophic epidermolyisis bullosa (RDEB). We provide the management and prognosis of cSCC in RDEB patients at a Spanish reference center.
Material and methods: We retrospectively included patients with RDEB attended in La Paz University Hospital (LPUH) from November 1988 to October 2018.
Results: Fourteen patients developed at least one cSCC. Tumors were predominantly well differentiated. Nearly half of the tumors have recurred. Median time to first recurrence was 23.4 months (95%CI:17.2- 29.5). Five patients have developed distant metastases. Median overall survival (mOS) was 136.5 months
since the diagnosis of the first cSCC (95%CI: 30.6-242.3). When distant metastases occurred, mOS was 6.78 months (95CI%: 1.94-11.61).
Conclusions: cSCC is a life-threatening complication of RDEB patients. Although tumors are usually well differentiated, they tend to relapse. This is the first Spanish report of cSCC arising in RDEB patients., The authors from UC3M-CIEMAT-CIBERER-IISFJD group are grateful for funding received from the Community of Madrid (AvanCell-CM: B2017/BMD-3692), from the European Union (GENEGRAFT: HEALTH-F2-2011-261392), from the Carlos III Institute of Health and ERDF, “Investing in your future” (AES_ICI14/00327- ICI14/00363), from ERDF/The Spanish Ministry of Science, Innovation and Universities – Agencia Estatal de Investigación (SAF2017-86810-R), and from the Patient Associations, Berritxuak and DEBRA España.
Project:
EC / FP7 261392